Cancer statistics in China, 2015.

PubWeight™: 12.92‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 26808342)

Published in CA Cancer J Clin on January 25, 2016


Wanqing Chen1, Rongshou Zheng2, Peter D Baade3, Siwei Zhang4, Hongmei Zeng4, Freddie Bray5, Ahmedin Jemal6, Xue Qin Yu7,8, Jie He9

Author Affiliations

1: Deputy Director, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China.
2: Associate Researcher, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China.
3: Senior Research Fellow, Cancer Council Queensland, Brisbane, Queensland, Australia.
4: Associate Professor, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China.
5: Head, Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
6: Vice President, Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.
7: Research Fellow, Cancer Council New South Wales, Sydney, New South Wales, Australia.
8: Adjunct Lecturer, Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
9: Director, National Cancer Center, Beijing, China.

Associated clinical trials:

Clinical Application of CTDNA in Operable Breast Cancer Patients | NCT02797652

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer | NCT02745847

Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer (CLASS02-01) | NCT03007550

China Lymphoma Patient Registry Study (CLAP) | NCT03313271

Adjuvant Chemotherapy for High Post-operative Recurrence Risk Stage pI Lung Adenocarcinoma (ACTPI) | NCT03380468

Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making (RECOMMEND) | NCT03413514

Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer | NCT03659578

Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy | NCT03734952

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage | NCT03847857

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer | NCT03970694

Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence (SOARAMIOCC) | NCT04022018

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | NCT04025840

Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC | NCT04182698

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery | NCT04209218

The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer | NCT04212598

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer | NCT04289792

Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep Learning | NCT04407039

Carrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable CNLC Stage IIa/IIb Hepatocellular Carcinoma | NCT04521153

Articles citing this

(truncated to the top 100)

A panel of four genes accurately differentiates benign from malignant thyroid nodules. J Exp Clin Cancer Res (2016) 1.40

Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer. Oncotarget (2016) 0.94

Long non-coding RNA UCA1 is a predictive biomarker of cancer. Oncotarget (2016) 0.88

Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) Study. EBioMedicine (2016) 0.88

RGB and HSV quantitative analysis of autofluorescence bronchoscopy used for characterization and identification of bronchopulmonary cancer. Cancer Med (2016) 0.87

Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model. Sci Rep (2016) 0.86

Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition. Oncotarget (2016) 0.84

Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal transition. Onco Targets Ther (2016) 0.84

A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients. Oncotarget (2016) 0.83

Progress in systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol (2016) 0.83

Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer. BMC Cancer (2016) 0.83

Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization. J Exp Clin Cancer Res (2016) 0.83

Discovery of Anticancer Agents of Diverse Natural Origin. Anticancer Res (2016) 0.83

Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep (2016) 0.82

Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. Nat Genet (2016) 0.82

Estimated cancer incidence and mortality in Hebei province, 2012. Chin J Cancer Res (2016) 0.82

Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis. J Cancer Res Clin Oncol (2016) 0.82

Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer. Oncotarget (2016) 0.82

Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing. Oncotarget (2016) 0.81

LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis. Oncotarget (2016) 0.81

The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis. PLoS One (2016) 0.81

Clinicopathologic study of invasive micropapillary carcinoma of the breast. Oncotarget (2017) 0.81

Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center. Oncotarget (2016) 0.80

Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study. Oncotarget (2016) 0.80

Temporal Trends in Geographical Variation in Breast Cancer Mortality in China, 1973-2005: An Analysis of Nationwide Surveys on Cause of Death. Int J Environ Res Public Health (2016) 0.80

Long noncoding RNAs in head and neck cancer. Oncotarget (2016) 0.80

Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer. Oncotarget (2016) 0.80

Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget (2016) 0.80

Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis. Oncotarget (2016) 0.80

Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res (2016) 0.80

Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway. Biomed Res Int (2016) 0.80

MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway. Aging (Albany NY) (2016) 0.79

Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer. J Cancer Res Clin Oncol (2017) 0.79

Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population. Oncotarget (2016) 0.79

Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma. Oncotarget (2016) 0.79

Epidemiological Trends in Colorectal Cancer in China: An Ecological Study. Dig Dis Sci (2016) 0.79

Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing. J Gynecol Oncol (2017) 0.79

Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. BMC Cancer (2016) 0.79

Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases. Oncotarget (2016) 0.79

Clinicopathological characteristics and long-term prognosis of screening detected non-palpable breast cancer by ultrasound in hospital-based Chinese population (2001-2014). Oncotarget (2016) 0.79

Correlation between Helicobacter pylori-associated gastric diseases and colorectal neoplasia. World J Gastroenterol (2016) 0.79

Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls. Oncotarget (2016) 0.79

MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res (2016) 0.79

Comparison of the 7(th) and proposed 8(th) editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery. Sci Rep (2016) 0.79

Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer. PLoS One (2016) 0.79

Association between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population. Oncol Lett (2016) 0.79

Environmental factors, seven GWAS-identified susceptibility loci, and risk of gastric cancer and its precursors in a Chinese population. Cancer Med (2017) 0.78

Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer Res Clin Oncol (2017) 0.78

miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Cell Death Dis (2016) 0.78

Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma. Oncotarget (2016) 0.78

Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer. Oncotarget (2016) 0.78

Did dose escalated radiotherapy in stage III non-small cell lung cancer improve overall survival? J Thorac Dis (2016) 0.78

Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China. BMC Gastroenterol (2017) 0.78

Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy. Cell Death Discov (2016) 0.78

Safety and outcome of external beam radiation and neutron brachytherapy in elderly patients with esophageal squamous cell cancer. J Contemp Brachytherapy (2017) 0.78

Incidence, mortality and survival of female breast cancer during 2003-2011 in Jiangsu province, China. Chin J Cancer Res (2016) 0.78

Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway. Oncotarget (2016) 0.78

The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma. Onco Targets Ther (2016) 0.78

Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer. Theranostics (2017) 0.78

Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis. Onco Targets Ther (2016) 0.78

Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study. Cancer Med (2016) 0.78

Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer. Onco Targets Ther (2016) 0.78

Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population. J Cell Mol Med (2016) 0.78

ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget (2016) 0.78

Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma. Oncotarget (2016) 0.78

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly. Medicine (Baltimore) (2016) 0.78

Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.78

Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study. Onco Targets Ther (2016) 0.78

Increased HPV L1 gene methylation and multiple infection status lead to the difference of cervical epithelial cell lesion in different ethnic women of Xinjiang, China. Medicine (Baltimore) (2017) 0.78

A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma. Br J Cancer (2016) 0.78

Clinicopathological features and prognosis of gastric cancer in young patients. BMC Cancer (2016) 0.78

miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Oncotarget (2016) 0.78

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy. J Cancer (2017) 0.78

Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour proliferation and promotes apoptosis in Non-small cell lung cancer. J Cell Mol Med (2017) 0.78

Prognostic value of RDW in cancers: a systematic review and meta-analysis. Oncotarget (2016) 0.77

Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy. Oncotarget (2016) 0.77

Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating TLR4 Signaling to NFκB, Upregulating Expression of microRNA-21. Gastroenterology (2016) 0.77

Tumor necrosis factor-alpha promoter polymorphism 308 G/A is not significantly associated with esophageal cancer risk: a meta-analysis. Oncotarget (2016) 0.77

MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival. Oncotarget (2016) 0.77

Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials. Onco Targets Ther (2017) 0.77

Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a. Oncotarget (2016) 0.77

Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis. Biomed Res Int (2016) 0.77

miR-134: A Human Cancer Suppressor? Mol Ther Nucleic Acids (2016) 0.77

A Homogeneous Polysaccharide from Fructus Schisandra chinensis (Turz.) Baill Induces Mitochondrial Apoptosis through the Hsp90/AKT Signalling Pathway in HepG2 Cells. Int J Mol Sci (2016) 0.77

14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/snail signaling pathway. Oncotarget (2016) 0.77

Precise integrin-targeting near-infrared imaging-guided surgical method increases surgical qualification of peritoneal carcinomatosis from gastric cancer in mice. Oncotarget (2017) 0.77

miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2. Br J Cancer (2016) 0.77

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer. Oncotarget (2016) 0.77

Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice. Oncotarget (2016) 0.77

Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients. Oncotarget (2016) 0.77

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. Oncotarget (2016) 0.77

CD317 Promotes the survival of cancer cells through apoptosis-inducing factor. J Exp Clin Cancer Res (2016) 0.77

ATF3 suppresses ESCC via downregulation of ID1. Oncol Lett (2016) 0.77

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Oncotarget (2016) 0.77

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection. Onco Targets Ther (2016) 0.77

Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China. Sci Rep (2016) 0.77

The monocyte to red blood cell count ratio is a strong predictor of postoperative survival in colorectal cancer patients: The Fujian prospective investigation of cancer (FIESTA) study. J Cancer (2017) 0.77

Mucosa-associated microbiota signature in colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.77

CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis. PLoS One (2016) 0.76

Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. J Cancer Res Clin Oncol (2016) 0.76

Articles by these authors

Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin (2015) 1.55